All stock lists
PicoCELA Inc. (NASDAQ:PCLA)
JP · Delayed Price · Currency is USD
Communication Services · Telecommunications Services
11.10+5.13 (+86.09%)
Market cap
$10.2M
Insider Score
Health Score
Listed since
Jan 16, 2025
Website
Insider Score
––Not scored
PCLA Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Weak
From PCLA’s reported statements · Q1 2026 (trailing 12 months)
Profitability0 / 20
Loses money on what it sells.
- Revenue
- $936.1M
- Net income
- -$3.20B
- Net margin
- -342.0%
Leverage16 / 20
Little or no net debt.
- Total debt
- $73.6M
- Cash
- $186.0M
- Debt / equity
- 0.37
Liquidity17 / 20
Comfortably covers what is due within a year.
- Current assets
- $569.6M
- Current liabilities
- $322.8M
- Current ratio
- 1.76
Cash generation0 / 20
Consumes cash and must keep raising it.
- Operating cash flow
- -$721.1M
- Free cash flow
- -$753.9M
- FCF margin
- -80.5%
Dilution & runway0 / 20
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 2.5M
- Share growth (1y)
- 214.4%
- Cash runway
- 3 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
PCLA Income Statement
| Fiscal Period | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|
| Period Ending | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 |
| Revenue | 364.17 M | 299.54 M | 146.05 M | 126.29 M | 126.29 M | 252.96 M |
| Revenue Growth (YoY) | 188.36 % | 18.42 % | -42.26 % | -9.30 % | -9.30 % | 14.44 % |
| Cost of Revenue | 153.07 M | 149.80 M | 73.04 M | 54.00 M | 54.00 M | 115.76 M |
| Gross Profit | 211.10 M | 149.75 M | 73.01 M | 72.29 M | 72.29 M | 137.20 M |
| SG&A Expense | 2.78 B | 457.68 M | 228.71 M | 217.31 M | 217.31 M | 202.79 M |
| R&D Expense | 6.24 M | 11.38 M | 5.55 M | 7.55 M | 7.55 M | 4.90 M |
| Operating Expenses | 2.78 B | 469.06 M | 228.71 M | 217.31 M | 217.31 M | 202.79 M |
| Operating Income | -2.57 B | -319.32 M | -155.69 M | -145.02 M | -145.02 M | -65.59 M |
| Pretax Income | -2.57 B | -317.98 M | -155.04 M | -158.11 M | -158.11 M | -81.05 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -2.57 B | -317.98 M | -155.04 M | -158.11 M | -158.11 M | -81.05 M |
| EPS (Basic) | -1037.39 | -9.18 | -148.38 | -200.70 | -200.70 | -168.00 |
| EPS (Diluted) | -1037.39 | -9.18 | -148.42 | -200.70 | -200.70 | -168.30 |
| Shares Outstanding | 2.48 M | 916.55 K | 1.04 M | 788.18 K | 788.18 K | 481.86 K |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.